118 related articles for article (PubMed ID: 38938213)
1. Role of the gut microbiota in cefoperazone/sulbactam-induced epilepsy in mice with chronic renal failure.
Wu Y; Gu D; Li J; Li J; Hou G
Ren Fail; 2024 Dec; 46(2):2371551. PubMed ID: 38938213
[TBL] [Abstract][Full Text] [Related]
2. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-induced microbiome depletion promotes intestinal colonization by Campylobacter jejuni in mice.
Chen H; Zhang Y; Pan Y; Wu L; Wang W; Zhang H; Lou H
BMC Microbiol; 2024 May; 24(1):156. PubMed ID: 38724913
[TBL] [Abstract][Full Text] [Related]
4. First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat.
Citraro R; Lembo F; De Caro C; Tallarico M; Coretti L; Iannone LF; Leo A; Palumbo D; Cuomo M; Buommino E; Nesci V; Marascio N; Iannone M; Quirino A; Russo R; Calignano A; Constanti A; Russo E; De Sarro G
Epilepsia; 2021 Feb; 62(2):529-541. PubMed ID: 33428780
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation.
Luo J; Wang Z; Fan B; Wang L; Liu M; An Z; Zhao X
Food Funct; 2021 Oct; 12(19):9087-9097. PubMed ID: 34388231
[TBL] [Abstract][Full Text] [Related]
6. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
Tian Z; Liu J; Liao M; Li W; Zou J; Han X; Kuang M; Shen W; Li H
Dig Dis Sci; 2016 Aug; 61(8):2262-2271. PubMed ID: 26846120
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation.
Zhang W; Zou G; Li B; Du X; Sun Z; Sun Y; Jiang X
J Microbiol Biotechnol; 2020 Aug; 30(8):1132-1141. PubMed ID: 32423189
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
[TBL] [Abstract][Full Text] [Related]
9. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy.
Kebede V; Ravizza T; Balosso S; Di Sapia R; Canali L; Soldi S; Galletti S; Papazlatani C; Karas PA; Vasileiadis S; Sforzini A; Pasetto L; Bonetto V; Vezzani A; Vesci L
Brain Behav Immun; 2024 Jul; 119():363-380. PubMed ID: 38608741
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model.
Fasching CE; Moody JA; Sinn LM; Tenquist J; Gerding DN; Peterson LR
Diagn Microbiol Infect Dis; 1991; 14(2):147-55. PubMed ID: 1873973
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
13. The effect of fecal microbiota transplantation on antibiotic-associated diarrhea and its impact on gut microbiota.
Wang L; Guo G; Xu Y; Li L; Yang B; Zhao D; Tian H; Ye C; Lin Z; Cui J; Li N; Huang L; Chen Q
BMC Microbiol; 2024 May; 24(1):160. PubMed ID: 38724904
[TBL] [Abstract][Full Text] [Related]
14. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation affects the recovery of AD-skin lesions and enhances gut microbiota homeostasis.
Jiang X; Liu Z; Ma Y; Miao L; Zhao K; Wang D; Wang M; Ruan H; Xu F; Zhou Q; Xu S
Int Immunopharmacol; 2023 May; 118():110005. PubMed ID: 36924566
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation attenuates Escherichia coli infected outgrowth by modulating the intestinal microbiome.
Wang Y; He Y; Liang Y; Liu H; Chen X; Kulyar MF; Shahzad A; Wei K; Li K
Microb Cell Fact; 2023 Feb; 22(1):30. PubMed ID: 36803386
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment.
Liu SX; Li YH; Dai WK; Li XS; Qiu CZ; Ruan ML; Zou B; Dong C; Liu YH; He JY; Huang ZH; Shu SN
World J Gastroenterol; 2017 Dec; 23(48):8570-8581. PubMed ID: 29358865
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model.
Zhong Y; Cao J; Ma Y; Zhang Y; Liu J; Wang H
Front Immunol; 2022; 13():842669. PubMed ID: 35185934
[TBL] [Abstract][Full Text] [Related]
19. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
[TBL] [Abstract][Full Text] [Related]
20. Use of cefoperazone/sulbactam in neonates.
Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
